CARGO Therapeutics (CRGX) deck
CARGO Therapeutics is a privately-held biotechnology company that researches and develops chimeric antigen receptor (CAR) T-cell therapies for cancer.
![](/content/images/size/w1304/2023/11/01-3.png)
CARGO Therapeutics is a privately-held biotechnology company that researches and develops chimeric antigen receptor (CAR) T-cell therapies for cancer.